Tag: Insulin therapy

Approximately 40–50% of adults and 20% of adolescents with cystic fibrosis (CF) will develop cystic fibrosis-related diabetes (CFRD). Unlike other forms of diabetes, managing CFRD requires a unique approach that prioritizes high-calorie and high-fat intake while carefully balancing carbohydrate intake with insulin to support overall health and weight maintenance.

Born in 1885, American physician Russell Morse Wilder was a pioneering figure in the fields of diabetes, epilepsy, and nutritional research. His credentials include a Ph.D. in pathology and an M.D., with a career defined by groundbreaking work at the Mayo Clinic, where he developed the classic ketogenic diet for epilepsy and became an early adopter of insulin therapy.

According to the CDC, the incidence of type 1 diabetes is rising, with more than half of new cases occurring in adults. Unlike type 2 diabetes, type 1 is an autoimmune condition where the body stops producing insulin, making nutrition a critical component of daily management rather than a preventative measure.

While hyperglycemia is the most common metabolic complication of parenteral nutrition (PN), hypoglycemia can occur and have severe consequences. It is often associated with the abrupt cessation of PN infusion, especially in vulnerable populations like young children.

For people with diabetes, carbohydrates have the most significant impact on blood glucose levels. For this reason, understanding **what is the purpose of carb counting?** is crucial for effectively managing health and achieving better glycemic control.

For people with diabetes who require mealtime insulin, accurate carbohydrate counting is a foundational skill for managing blood sugar levels. This practice becomes much more precise with a working knowledge of **what is the formula for the carb ratio?**, which is essential for calculating an appropriate insulin dose based on food intake.